Literature DB >> 29240026

Gemtuzumab Ozogamicin Containing Chemotherapy for Relapsed or Refractory Acute Myeloid Leukemia (AML) in Children.

Anthony Pak-Yin Liu1, Alex Wing-Kwan Leung2, Daniel Ka-Leung Cheuk1, Vincent Lee2, Shau-Yin Ha1.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2018        PMID： 29240026     DOI： 10.1097/MPH.0000000000001010

Source DB:  PubMed          Journal:  J Pediatr Hematol Oncol        ISSN： 1077-4114            Impact factor:   1.289


× No keyword cloud information.
  2 in total

1.  Acute Left Ventricular Dysfunction Following Gemtuzumab Ozogamicin in Two Pediatric AML Patients.

Authors:  Kevin O McNerney; Katelyn Oranges; Alix E Seif; Benjamin Oshrine; Bonnie Ky; Kimberly Y Lin; Kelly D Getz; Richard Aplenc
Journal:  J Pediatr Hematol Oncol       Date:  2022-03-01       Impact factor: 1.170

Review 2.  Invasive Fungal Diseases in Children with Hematological Malignancies Treated with Therapies That Target Cell Surface Antigens: Monoclonal Antibodies, Immune Checkpoint Inhibitors and CAR T-Cell Therapies.

Authors:  Ioannis Kyriakidis; Eleni Vasileiou; Claudia Rossig; Emmanuel Roilides; Andreas H Groll; Athanasios Tragiannidis
Journal:  J Fungi (Basel)       Date:  2021-03-05
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.